IAR-129

N/A

Report date: 2025/09/22 10:56:13

Base Information

Drug NameIAR-129
Drug Alias NameIAR-129IAR129
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Interleukin-4 receptorsAnti-Tumor necrosis factor ligand superfamily member 4
TargetsTumor necrosis factor ligand superfamily member 4Interleukin-4 receptors
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInnovent Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInnovent Biologics Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A